BEzafibrate Coronary Atherosclerosis Intervention Trial - BECAIT

Description:

The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) was a double-blind, placebo-controlled intervention trial, designed to assess the feasibility of retarding or preventing the progression of atherosclerotic lesions in young male survivors of myocardial infarction (MI) by dietary intervention and administration of bezafibrate.